Back to Agenda
Extraction of Essential Issues and Strategic Proposals for Domestic Implementation of Decentralized Clinical Trial
Speaker(s)
Maria Resnick
Boehringer-Ingelheim Japan, Japan
Lead, Strategic Feasibility & Innovation,
Steve Geffon
Science 37, United States
Chief Commercial Officer
Yoshihito Kondo, MPharm
CMIC HOLDINGS Co., Ltd., Japan
Executive Vice President, Clinical Operation
Shuji Ozawa
CMIC HOLDINGS., Ltd., Japan
Director, Future Design
Ikiru Matsumoto, MPharm, MSc
Fun-Well, Japan
President
Have an account?